PopulationsReview
Cardiovascular disease risk in patients with and without metabolic dysfunction-associated steatotic liver disease: A clinical and subclinical evaluation
American Heart Journal Plus
- Cardiovascular disease
- Metabolic dysfunction-associated steatotic liver disease
- Atherosclerosis
- Atrial fibrillation
- Coronary artery disease
- Humans
The paper
Omar MYAY, El-Mallah AME, Bakr MGMA et al.
American Heart Journal Plus · 29 Aug 2026
